Definitive Healthcare Q4 revenue $61.5M (-1% YoY); full year net loss includes $196.1M goodwill impairment

Definitive Healthcare Corp.

2025-FY EPS reported -$1.30 revenue$241,521,000

Q4 revenue $61.5M vs $62.3M prior year; adjusted EBITDA $18.0M (29% margin) vs $17.5M (28%).
Full year 2025 revenue $241.5M vs $252.2M; adjusted net income $34.9M vs $55.1M.
Net loss for full year 2025 was $199.3M, including $196.1M goodwill impairment; prior year loss $591.4M with $688.9M impairment.
Q1 2026 revenue guidance $54–56M; full year 2026 revenue guidance $220–226M, below 2025 actual of $241.5M.
Customer wins: large health system for Population Intelligence; global rare disease firm for US market expansion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.